{"id":7673,"date":"2015-05-06T15:56:15","date_gmt":"2015-05-06T13:56:15","guid":{"rendered":"https:\/\/faus-moliner.com\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/"},"modified":"2016-03-04T18:25:39","modified_gmt":"2016-03-04T16:25:39","slug":"los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico","status":"publish","type":"post","link":"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/","title":{"rendered":"Holders of marketing authorizations are entitled to judicially appeal  against the approval of a generic medicinal product"},"content":{"rendered":"<p><strong>Summary: <\/strong>In Spain and in other EU Member States, holders of marketing authorizations for reference medicinal products face obstacles when trying to bring national authorities to court in connection with the grant of generic approvals. In many cases, Spanish Courts have denied locus standi claiming that the interest that the claimant is not sufficient to bring the matter to Court because the damage that it may suffer as a result of the approval of the generic results not from the action of the administration but from the effective commercialization of the product.<\/p>\n<p>In the Olainfarm judgement of 23 October 2014, the ECJ ruled that holders of the MA for reference products must have the right to judicial review of the grant of approval for the generic if the rights that EU law grants to such holders have been violated.<\/p>\n<p>The rational of the Court is based on the Charter of Fundamental Rights of the European Union, and will require a review of Spanish case law in this matter.<\/p>\n<p>The Court also ruled that medicines approved on the basis of the \u201cwell-established use\u201d exemption may qualify as reference products.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Summary: In Spain and in other EU Member States, holders of marketing authorizations for reference medicinal products face obstacles when trying to bring national authorities to court in connection with the grant of generic approvals. In many cases, Spanish Courts have denied locus standi claiming that the interest that the claimant is not sufficient to&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/\" class=\"excerpt-read-more\">Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[390,217,71],"tags":[],"coauthors":[105],"class_list":["post-7673","post","type-post","status-publish","format-standard","hentry","category-generics-2","category-pharmaceutical-and-life-sciences-law-2","category-publications"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Holders of marketing authorizations are entitled to judicially appeal against the approval of a generic medicinal product - Faus Moliner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Holders of marketing authorizations are entitled to judicially appeal against the approval of a generic medicinal product - Faus Moliner\" \/>\n<meta property=\"og:description\" content=\"Summary: In Spain and in other EU Member States, holders of marketing authorizations for reference medicinal products face obstacles when trying to bring national authorities to court in connection with the grant of generic approvals. In many cases, Spanish Courts have denied locus standi claiming that the interest that the claimant is not sufficient to... Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/\" \/>\n<meta property=\"og:site_name\" content=\"Faus Moliner\" \/>\n<meta property=\"article:published_time\" content=\"2015-05-06T13:56:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-03-04T16:25:39+00:00\" \/>\n<meta name=\"author\" content=\"Jordi Faus\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jordi Faus\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/\"},\"author\":{\"name\":\"Jordi Faus\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\"},\"headline\":\"Holders of marketing authorizations are entitled to judicially appeal against the approval of a generic medicinal product\",\"datePublished\":\"2015-05-06T13:56:15+00:00\",\"dateModified\":\"2016-03-04T16:25:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/\"},\"wordCount\":203,\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"articleSection\":[\"Generics\",\"Pharmaceutical and Life Sciences Law\",\"Publications\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/\",\"url\":\"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/\",\"name\":\"Holders of marketing authorizations are entitled to judicially appeal against the approval of a generic medicinal product - Faus Moliner\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\"},\"datePublished\":\"2015-05-06T13:56:15+00:00\",\"dateModified\":\"2016-03-04T16:25:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/faus-moliner.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Holders of marketing authorizations are entitled to judicially appeal against the approval of a generic medicinal product\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"name\":\"faus-moliner.com\",\"description\":\"Otro sitio realizado con WordPress\",\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/faus-moliner.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\",\"name\":\"Faus Moliner\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"contentUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"width\":400,\"height\":283,\"caption\":\"Faus Moliner\"},\"image\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/2372042\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\",\"name\":\"Jordi Faus\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"caption\":\"Jordi Faus\"},\"description\":\"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.\",\"sameAs\":[\"https:\/\/faus-moliner.com\/\"],\"url\":\"https:\/\/faus-moliner.com\/en\/author\/jordi-faus\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Holders of marketing authorizations are entitled to judicially appeal against the approval of a generic medicinal product - Faus Moliner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/","og_locale":"en_US","og_type":"article","og_title":"Holders of marketing authorizations are entitled to judicially appeal against the approval of a generic medicinal product - Faus Moliner","og_description":"Summary: In Spain and in other EU Member States, holders of marketing authorizations for reference medicinal products face obstacles when trying to bring national authorities to court in connection with the grant of generic approvals. In many cases, Spanish Courts have denied locus standi claiming that the interest that the claimant is not sufficient to... Read More","og_url":"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/","og_site_name":"Faus Moliner","article_published_time":"2015-05-06T13:56:15+00:00","article_modified_time":"2016-03-04T16:25:39+00:00","author":"Jordi Faus","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jordi Faus","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/#article","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/"},"author":{"name":"Jordi Faus","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260"},"headline":"Holders of marketing authorizations are entitled to judicially appeal against the approval of a generic medicinal product","datePublished":"2015-05-06T13:56:15+00:00","dateModified":"2016-03-04T16:25:39+00:00","mainEntityOfPage":{"@id":"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/"},"wordCount":203,"publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"articleSection":["Generics","Pharmaceutical and Life Sciences Law","Publications"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/","url":"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/","name":"Holders of marketing authorizations are entitled to judicially appeal against the approval of a generic medicinal product - Faus Moliner","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/#website"},"datePublished":"2015-05-06T13:56:15+00:00","dateModified":"2016-03-04T16:25:39+00:00","breadcrumb":{"@id":"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/faus-moliner.com\/en\/los-titulares-de-autorizaciones-de-comercializacion-estan-legitimados-para-recurrir-judicialmente-contra-la-aprobacion-de-un-generico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/faus-moliner.com\/en\/"},{"@type":"ListItem","position":2,"name":"Holders of marketing authorizations are entitled to judicially appeal against the approval of a generic medicinal product"}]},{"@type":"WebSite","@id":"https:\/\/faus-moliner.com\/en\/#website","url":"https:\/\/faus-moliner.com\/en\/","name":"faus-moliner.com","description":"Otro sitio realizado con WordPress","publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/faus-moliner.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/faus-moliner.com\/en\/#organization","name":"Faus Moliner","url":"https:\/\/faus-moliner.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","contentUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","width":400,"height":283,"caption":"Faus Moliner"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/2372042\/admin\/"]},{"@type":"Person","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260","name":"Jordi Faus","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5","url":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","caption":"Jordi Faus"},"description":"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.","sameAs":["https:\/\/faus-moliner.com\/"],"url":"https:\/\/faus-moliner.com\/en\/author\/jordi-faus\/"}]}},"_links":{"self":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/7673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/comments?post=7673"}],"version-history":[{"count":0,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/7673\/revisions"}],"wp:attachment":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/media?parent=7673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/categories?post=7673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/tags?post=7673"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/coauthors?post=7673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}